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CERVICAL CANCER ; TEST AND PREVENTION 
The main target group for this bachelor’s thesis was mainly the female, having just basic 
information on cervical cancer the author sought to know more on cervical cancer in depth 
forcusing closely on the cause of cervical cancer,ways of testing cervical cancer as well as 
possible ways of prevention. A few of treatment methods have been mentioned although 
not much emphasis was put on it since the author was dealing mainly with prevention.  
The main aim of these bachelor’s thesis paper is to give efficient information on the 
different screening methods available in order to fight against cervical cancer and 
contribute to the mortality decrease as a result of the HPV virus. The aim is to grasp the 
attention of especially the female gender and enrich them with awareness and the needed 
knowledge regarding cervical cancer. 
Materials used to collect information came from different sources, most were peer reviewed 
articles that were searched by using keywords on google, this was done in order to ensure 
that the aricles were relevant and related to the topic. Cervical cancer related organisation’s 
webpages were also reffered to for information.  
A variety of cervical cancer screening methods were found and compaired against each 
other to find most suitable methods. Information on vaccines available were also found as 
well as information on how they are used and groups suitable for their use. 
The study was found to be productive and suitable for use for reference for women that 
want to find information on cervical cancer and ways by which they can egin to work on 
preventing themselves from HPV infection or development of cervical cancer. 
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1 INTRODUCTION 
According to the world health organization (WHO 2002) cervical cancer is said 
to be the world´s second deadly cancer with an estimate of about 493,243 
women diagnosed with it and 273,505 dying from it per year. Cervical cancer is 
also the world´s second most frequent among women between 15 and 44 years 
of age. In Finland about 2.23 million women aged 15 years and over are at risk 
of getting cervical cancer, current estimation states that out of 164 diagnosed 
with cervical cancer per year about 81 of them die as a result of the disease. It 
is the 15th most common cancer in Finland and the 4th most common cancer 
among the women in Finland.  (WHO 2002.) 
Cervical cancer was once known as the most deadly cancer  in America until the 
years 1955 to 1992 when its rates decresed by 70% due to increase in pap 
smear screening and more awareness among society, it is said to decline by 3% 
each year but the numbers still remain high. According to the American Cancer 
Society  recent estimate states that in the year 2011 about 12,710 new cases of 
invasive cancer will be diagnosed and of these about 4,290 deaths will be 
recorded. (American Cancer Society 2010.)  
Cervical cancer is as a result of Human PapillomaVirus which is transmitted 
through sexual intercourse, in most cases the male is a career of the pailloma 
virus that infects and generates in females. Despite the risks of the HPV virus 
both males and females are are hardly aware of the virus and the risks it 
carries. (Roland et al 2009, 5.) 
In America within an estimate of every six minutes a gynecological cancer is 
diagnosed with the majority being  cervical cancer among women of the ages 
40-55 years of age. In 2007 and average of about 12,000 to 16,000 females 
were diagnosed with cervical cancer. (Godfrey 2007, 1397.) 
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Cancer fatalism has continued to increase among especially young women, this 
is the belief that women have had that diagnosis of cancer directly translates to 
inevitable death therefore they find it better to avoid going for screening and are 
with no knowledge whatsoever on their health status. Education and Knowledge 
on both breast cancer and cervical cancer has continued to decrease as the 
cancer fatalism increases not because there is no available information but 
because the women have been ignorant to enlighten themselves. (Powe 2006, 
2.) 
 
2  LITERATURE REVIEW 
The cervix is located in the lower part of the uterus also called uterine cervix, it 
connects the body of the uterus by the cervix part called endocervix to the birth 
canal by the part named exocervix. Cells covering the cervix are referred to as 
squamous cells and the glandular cells  (American Cancer Society, 2010.) 
Cervical cancers is a cancer malignant of the cervix or within the cervical area.It 
may form in the interior lining of the cervix, junction of the vagina and the 
uterus. (Saonere 2010, 314- 323). Cervical cancer  begins to develop in the 
cells around the cervix. Pre-cancerous cells which are described as cervical 
intraepithelial neoplasia (CIN), squamous intraepithelial lesion (SIL) and 
dysplasia. The pre-cancerous cells cancer can fully grow into cancer. There are 
two main forms of cervical cancer namely squamous cell carcinoma and 
adenocarcinoma, of these types 80% to 90% of the cervical cancers are due to 
the squamous cell carcinoma which begin where the exocervix joins the 
endocervix. Cervical adenocarcinoma develops from the mucus-producing 
gland cells of the endocervix. (ACS 2010.)  In some cases some of the cancers 
can be as a result of a combination of both squamous cells carcinoma and 
adenocarcinoma, the carcinoma is known as adenosquamous carcinoma or 
mixed carcinoma. In some women precancerous cells go away with no 
treatment whatsoever while others turn into true invasive cancers. (ACS 2010.) 
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There are other rare types of cervical cancer that may occur namely primary 
cervical lymphoma that involves the lymphnodes on the cervical area. However 
this does not commonly occur. In 2005 there were less that 60 cases of this 
kind of cervical cancer. Neuroendocrine cervical  cancer is one of the 
aggressive tumors that are hard to discover or at times may be misdiagnosed. 
Malenoma of the cervix can be formed as a result of migrated metastasized 
lesion from any other part of the body.  Adenoid cystic carcinoma of the cervix 
forms mostly in elderly group of patients in the early stages of the diagnosis. 
(Saonere 2010, 314- 323.) 
Diagnosis of cervical cancer that helps to define the different stages can be 
classified by the use of the histopathological criteria which follows the royal 
college of pathologists. The reports of the cervical tumors indicate the type of 
tumor,size and extent of the tumor. Also the depth and pattern of invasion could 
be determined. Lymphovascular space invasion, possible presence of the tumor 
and its distance from margin. Status of the lymph nodes and any indication of 
invasion or any presence of pre-invasive disease. This assessment should be 
thoroughly done and well standardized since the diagnosis done determines the 
start and path of treatment. (Scottish Intercollegiate Guidelines Network  2008.)  
There are a variety of stages of cervical cancer that identify the extent and site 
of infection. The first stage is stage 0 which is also in another name known as 
cervical carcinoma in situ, it is located at the top layer of cells along the cervix 
line Carcinoma in situ is not considered as a cancer but in some cases it may 
develop into cancer if left untreated.  (Cancer Research UK  2011.)  
 
Stage 1 cervical cancer is only found in the cerv ix. Stage 1 is further divided 
into two groups A and B. In stage 1A only a small microscopic cancer is in the 
cervical tissue and is about 5-7 milimeters, the stage 1B may be just slightly 
wider than 7 milimeters and may be as large as 4 centimeters that can be 
visible even without a microscope. Stage 2 cervical cancer spreads from the 
cervix into the upper part of the vagina .Stage 2A means it has spread to about 
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two thirds of the vagina but having not touched the other surrounding tissues of 
the utherus unlike stage 2B where it may slightly spread into other tissues 
around the uterus  as along with the two thirds of the vagina. Stage 3 cervical 
cancer spread into the lower part of the vagina and spread to the pelvic wall and 
the surrounding lymph nodes. In 3A cervical cancer spreads to the lower third of 
the vagina but does not affect the pelvic wall. Stage 3B cervical cancer spreads 
to pelvic wall,the tumor is large enough that it could block the ureters causing 
the risk of the kidney to enlarge or even sieze to function with the risk of also 
having lymph nodes infected. The most crusual stage is Stage 4 which has 
cervical cancer spread to the bladder, rectum and even other parts of the body. 
In the stage 4B the cervical cancer may even spread to the liver, intestinal tract 
or lungs causing it to be a very deadly level.  (Saonere et al 2010, 314-323.) 
Cervical cancer has continuously been striking hard on the poorest countries 
such as central and south America, the caribean, sub-saharan Africa , some 
parts of oceania and Asia with rates as high as 30 per 100,000 women, 
compared with North America and Europe that have reports of about 10 per 
100,00 cases. Approximately 1.4 million women worldwide living with cervical 
cancer  and India may account for more that one-fourth of the total reporting 
nearly  132,000 new cases annually. A small population of   women from the 
poor and developed countries that receive cervical cancer treatments therefore 
having a window of 7 million women worldwide inclusive of possible 
precancerous conditions that have not been identified. (ACCP 2004.)  
 
Develping countries have continued to increase the stress of the importance of 
breast cancer while over the years yet cervical cancer has reigned as a major 
cause of morbidity and mortality greatly due to the level of awareness both 
among society and healthcare providers as opposed to developed countries 
such as finland that has been records of increase in HPV virus without  affecting 
the mortality. (WHO 2002.)  
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In the year 2000 there were up to 47,100 new reported cases of  cervical 
cancers and 288 000 of these ending up in death worldwide. About 80% of 
these cases were from develioping countries. (WHO 2002, 5.) In 2008  there 
were 529,800 new cases  of cervical cancer that were reported accounting for 
9% of the worldwide cancers and  275,100 deaths making 8% of the cancer 
deaths. In total 56% for these cases and 64% of the total deaths were from 
developijg countries.  Differences betweem the mortality rates in developing 
countries compared to developed countries is highly notable in the table below, 
this is due to the response to cervical cancer campaigns that have been carried 
ou. Wome in developed countries are faily exped to much more information, 
medical facilities and vaccines are available. In developing countries however 
the social economic state does not allow the cervical cancer to be a lead 
consideration factor, however some significant decrease in mortality may be 
credited to availed cheaper methods of screening. (Jemal et al 2011, 79-80.) 
SEE TABLE 1 
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Table 1. Incidents and mortality of cervical cancer in 2008. Source; Jemal 
2011,8. http://onlinelibrary.wiley.com/doi/10.3322/caac.20107/pdf Updated 
9.5.2011 
 
2.1 Risk factors  
The HPV virus  infection which is the infection mainly responsible for cervical 
cancer is  transmitted through sexual intercourse. There are about 100 different 
types of HPV viruses but only about 40 of these types affect the genital areas. 
Some of the other types infect the skin on other body areas like the hands, or 
feet. Genital warts known as condylomata acumination are usually small, flat 
cauliflower like bumps that carry HPV virus even though at times it is in small 
percentage therefore not necessarily at  risk of causing cervical cancer. Types 6 
and 11 are responsible for the causing of the warts which develop in a period of 
six weeks to eight months. (Likes  & Itano 2003, 272).  
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HPV virus hardly has any symptoms therefore causing it to be very hard to 
identify hence the need to go for cervical checkup and HPV testing (Godfrey 
2007,1399). There are a total of 13 high risk HPV types that can cause low-
grade cervical cell abnormalities. The high risk types have been detected in 
90% of the cervical cancer tests with 70% of these being from  HPV types 16 
and 18. Infection by one type of HPV virus does not guaranty that a person is 
not suseptable to infection by a second or more types, among people infected 
with mucosal HPV about 5% to 30% get infected with more than one type of 
virus simultaneously. (Pink book 2011, 140. ) 
A woman having multiple sexual partners puts her at   higher risk of acquiring 
the HPV infection which is dominant in men. (Like &Italo 2003, 272). However 
“A woman´s risk of cervical cancer depends less on her own sexual behavior 
than on that of her husband or other male partners”. (Castellsague et al. 2003, 
346). By this hypothesis the author  pointed out clearly on how men at that time 
and age are  more promiscuous than women were know to be, unlike women 
majority of men are just carriers of the HPV virus and can transfer from one 
partner to another with them not getting any infection. Unfortunately with the 
new generation of reckless sexual behaviours that are equally evident among 
both genders increase the risk of infection of cervical cancer. In some other  
cases the HPV infection cells may be generated faster through direct 
carcinogenic actions that are aided by long term use of contraceptives also 
contribute greatly to the HPV virus development, contraceptives act as a 
generative agent with an increase of 2.2 folds increase in risk level although 
there has been no link clearly explaining the relation between the 
contraceptives and HPV virus. (Likes & Itano 2003, 273- 275.)  
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Women that have had three or more full term pregnancies are also said to be 
high risk patients. This is seen to be due to the different hormonal changes that 
make the women more susceptible to HPV infection. It is also considered a high  
risk for young aged women at about 17 years of age or younger when they have 
had their  first full time pregnancies.They are  twice more  at risk of have 
cervical cancer later on in life compared with women that get pregnant at 25 
years and over. (American Cancer Society 2010, 6.) 
Diethylstilbestrol (DES) which is a hormonal drug for women with high chances 
of miscarriage given between the year 1940 to 1971 has been found to be of 
high risk not to the women taking drugs but the women’s daughters. About 1 in 
1000 of these women develop cervical cancer. Those whose mothers took the 
drug during the first 16 weeks of pregnancy where found to be of higher risk. 
The drug however no longer in use. Family medical history can be a major risk 
factor for any female not just those that mother’s used the diethylstilbestrol 
hormone medication but also women whose family has a history of cervical 
cancer. (Herbert & Coffin 2008, 66-67.) 
Chlamidya trachomatis  a bacteria that infects the reproductive system is the 
most common sexually transmitted bacterial infection that  has  been found to 
have effect on the cervical intraepithelial neoplasia (CIN) grade 2, it is an 
independent co-factor to the development of cercial neoplasia meaning that  
chlamydia does not cause the HPV virus or cervical cancer but is a high risk in 
aiding its development  at early stages of cervical carcinogenesis . (Lehtinen et 
al. 2011, 372-375.) Like most STD’s chlamydia is well preventable by the use of 
condoms, in the case of HPV infection the use of condoms as a primary 
prevention strategy has been scientifically identified to be unsuccessful, 
however condoms are a way of reducing the risks brought about by the STD’s 
such as HIV/AIID, chlamydia and genital herpes which all depress body immune 
system increasing the risk of cervical cancer. (Herbert & Coffin 2008, 65-66.) 
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 According to the WHO 2002 there are a total of over one thousand million 
smokers worldwide, though the population of developing countries smoking 
women is decreasing there is still a sighnificant number still participating in the 
habit while in developed countries the habit continous to be more popular 
among the women closely getting equal to the number of men smoking. (WHO 
2002.) Smoking whether active or passive has been found to be high risk factor. 
A strong coorelation has been found between smoking habits and sexual 
behaviours in social settings in many populations. Chemicals substances in the 
cigarettes have also been detected in cervical mucus therefore aiding in 
development of cervical cancer by causing damage on DNA around the cervical 
cells. (Özgul 2009, 349.) 
Some cultural and religious beliefs that keep the women away from the 
screening programmes. An example of such communities are the chamorro 
women of the Micronesia who are raised with the Mamahloa religion. Which 
calls for a sense of shame in women in exposing anything on their sexuality or 
gynecological health hence keeping them away from the health centers. Due to 
this cervical cancer has remained to be the second leading concern of death 
among the women of ths community and the third highest behind Asian and 
caucasian women. (Rosario 2011, 81-82.) 
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2.2 Signs and symptoms 
A number of signs and symptoms of cervical cancer are associated mainly with 
the later stages of the infection which are CIN 3-4 but studies have also shown 
that about 15.7% to 32% of the women with the early stages of cervical cancer 
disease also have symptoms at presentation (SIGN 2008). 
Some of the signs and symptoms for cervical cancer can be common to those 
of genital Chlamydia trachomatis infection, Post-menopausal bleeding may be a 
symptom of endometrial cancer and these group of women require pelvic 
examination during the assessment, abnormal vaginal bleeding such as inter-
menstrual bleeding (IMB) or post-coital bleeding (PCB) is also a common 
symptom, however in women under the age of 25 years the chances of having 
cervical cancer when experiencing PCB is less than that of women women over 
35 years of age which creates higher chances (Imagines 2008.) Pain around 
the cervical area may be experienced during sexual intercourse. In an 
advanced level of the cervical cancer there is great loss of appetite, weight loss, 
pelvic pain, back pains and leg pain. Heavy bleeding may be experienced from 
the vagina,leakage of urine or even presence of faeces extracting from the 
vagina. In some cases there maybe bone fractures around the pelvic area. 
(Saonere 2010, 314-323.) 
In advanced stages the woman may experience very heavy, straw.coloured, 
bloody strong smelling vaginal discharge that may have a mixture of blood, 
pulse like tissue, urine and stool that may lead to vaginal bacterial infection that 
produces smelly gasses. The bacteria is not completely eliminated but good 
hygene can control the smell coming from the discharge, antibiotics such as 
Doxycycline, amoxicillin and metronidazole may be taken although antibiotics 
can be a further risk to acquiring funal vaginitis as a side effect. Vesico-bleeding 
or recto-vaginal fistula may occur in some cases. This is when a hole forms 
between the vagina and the bladder causing leakage if urine uncontrollably from 
the vagina.In some cases the hole may be between the vagina and the rectum 
therefore causing stool to come off from the vagina. (PATH 2003.) 
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This happens mostly in the last stages of the cancer and cannot be medically or 
even surgically corrected. Dehydration may also occur due to the excess loss of 
fluid from the body through diarrhea, vomiting, high fever and not feeding the 
body with foods or even drinks o compensate the loss. (PATH 2003.) 
2.2 Screening 
With approximately of 270,000 deaths with 85 percent been  from developing 
countries, mortality increase  has been identified to be due to the lack of the of 
efficient high quality precancer screening and treatment resources as well as 
poor infrastructure. (Alliance For Cervical Cancer Prevention 2009). Cervical 
cancer is well preventable by screening especially on women that are 
asymptomatic for precancerous cervical cancer lesions early  detection leads to 
faster and more successful treatment. According to multiple studies that have 
been carried out women that have been screened for atleast once in their 
lifetime between ages 30 and 40 reduce cancer risk by 25-36%. (Cervical 
Cancer Action 2008).  
Evaluation of the alternative screening methods in screening programmes have 
been continuously studied to verify screening effiectiveness by comparing the 
various screening techniques available. Performances of these screening 
methods are well evaluated and monitored to see if they are precise and able to 
correctly give effectively accurate  feedback. It also helps to correctly identify 
the right testing ages and the suitable interval for the different screening 
techniques available. (Anttila et al 2006, 2.) 
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There has been an increase in the mortality rate among  developed countries 
regarding cervical cancer due to the imrprovement of screening techniques. 
Unlike developing countries where there are limitations of techniques. 
Organized programmes have been continuously implemented in developed 
countries. The programmes continue to be successful due to high level of 
management and funding by government organizations. In some of the 
countries women are actively invited to participate in screening programmes. 
(WHO 2002.) 
Despite the ongoing campaigns  to create cervical caner awareness a majority 
of women that go for a variety of  pelvic examiniation or  gynecological tests still 
tend to assume that the test automatically includes cervical cytological 
screening and this kind of mentality has continued to create major concerns of it 
being a contributing factor to cervical cancer since the women do not go for 
cervical cancer screening.(Fry 2010, 1715.) 
A survey was done in a women´s visit center where the women regularly go for 
urgent care,the aim of the study was to determine how much knowledge the 
women had on cervical cancer screening. The group of women given the survey 
questioners were those that spoke English and Spanish languages that came in 
to the center for pelvic tests. They were questioned on their  general knowledge 
on the pelvic tests that they had come into the center to receive and also the 
knowledge that they had of papilloma screening. After questioning the 
participants were offered education about pap smears both verbally and also 
from scripts that were printed for them to read freely in the women´s visit center, 
certified translators were availed for  clear translations for the Spanish group. 
The preintervention group had 382 participants while the post intervention group 
had 130 women of the mean age of 29.2 years. There was no major difference 
between the English and Spanish speaking group in age and gravidy, through a 
briviate analysis there was found to be an increase in women giving correct 
answers to the questions as compared to the case prior to the intervention, 
majority of the women could tell the difference between a general pelvic test 
and a pap smear test. ( Fry 2010,1715-1718.) 
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At the end of the survey 66.3% of the women felt that the exercise was helpful 
and educative on pap screening and its importance, this was a greater 
difference compared to the results from the pre-intervention group where only 
33.1% of the group appreciated and saw the importance of the women learning 
about the pap screening. (Fry 2010,1715-18.)  
Physicians and other health care workers carry the responsibility of ensuring 
that the patients visiting for vaccinations get the all the information available on 
the various kinds of screening methods available and the accessibility. There 
are many dilemas that the healthcare worker in terms of suitability of screening 
a patient. The first is the extent of risk involved as compared to the benefit of 
the screening. Cervical cancer screening can be a state that can cause 
psychological harm to the patietns due to anxiety,false positives can cause one 
to have distress and while undergoing unnecessary treatments. To reduce this 
anxiety the patient needs to be taken through the different methods available as 
well as the process by which the screening methods are undertaken, patients 
should be allowed to participate in the decision making on the method to be 
undertaken. Medical workers should also asses the social-economical state of a 
setting before they can decide on the screening method that they can 
recommend for their paients. This is because the screening methods vary in 
affordability and maintainance of equipments and therefore causing the 
screening methods to be expensive. If the methods are too expensive then the 
women that cannot afford the screening will not attend the screening 
programme.  Women also need to know that as they visit their physician or 
healthcare woker, they can trust that their visit would be kept confidencial.It is 
therefore the ethical duty of the healthcare worker to ensure that autonomy is 
maintained for every one that visits for screening. Maintaining the trust of a 
patient keeps a close relationship through test and possibly treatment of the 
patient. As mentioned before cervical cancer is a sensitive illness that most 
women do not feel comfortable to discuss with everyone and therefore seek 
confidence of their healthworkers. (Snadden 1992, 331-333.) 
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Exfolative cervicovaginal cytology; Also known as the  pap smear screening 
technique or conventional cytology screening it has been used from as far as 
1927 when papanicolau was introduced and has for many years been in use. In 
this technique pap smear collection is obtained from the cervix and the 
endocervical canal by the use of an Ayre  spatula and ctyobrush. Samples 
taken are then smeared on a slide which is then fixed with cytology fixative. The 
inaccuracy of this tests is about 5% to 10% cases which has been related with 
wrongfully taking the sample due to poor technic of sample collection, in some 
cases not all the sample collected is transferred  to the glass slide , in  some 
situations  only 20% of the collected sample   is possible to transfer. Sensitivity 
of the pap smear test is rated at 55-60% and in epidemiological data reports 
suggests that it is unlikely to detect 60% of the general cervical cancer cases. 
(Kerker 2006,115-122.) 
 Pap  smear screening has proven to be the most successful method of 
detecting cervical cancer and  has helped in decreasing morbidity and mortality 
brough about by cervical cancer. However about 30% of the results have errors 
which occur as a result of mistakes like incomplete sampling of the 
transformation zone  or the cytotechnologist failure to detect presence of 
abnormal cells on a slide, one way by which this risk of errors has been to 
reduce the workload of the cytotechnologists who screen a maximum of 100 
slides a day. (Nouvo 2001, 780-786.) 
 Liquid based cytology; Sample collection method is similar to that of the 
conventional pap smear method although a special sample collecting device 
that collects exfoliated cells from transformation zone of the cervix. (American 
collage of obstretricians  2009). The device is placed in a vial that contains 
preservative that contains hemolytic and mucolytic agents. In this technique 
there is even distribution of cells  with reduced cellular debris and RBC’s in the 
sample, this has highly decreased the incidents of positive false diagnosis of 
cytological atypia and  is better at detecting squamous abnormalities. (Kerka 
2006, 115-122.) 
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United states survey of 2003  indicated that the liquid based cytology (LBC) 
technique was found to be more commonly used compared to the pap 
screening technique  with over 90% of obstetrician-gynecologists and 
physicians preferring it to pap smear screening. Nationally representative 
studies showed that among outpatients visitors between 2006-2007 an 
approximate of 70% were tested using the liquid based cytology making it the 
most common method of screening presently. Inspite of its popularity there 
have been no differences spotted between LBC and pap smear techniques in 
terms of specifity and sensitivity, however the ease in interpreting microscopic 
readings measures as an advantage with the LBC. (Hing 2011, 2-8.) 
Visual screening; This type of screening involves direct inspection of the cervix 
without taking of samples and although it is less tedious in terms of preparation 
and inspection it is considered to be less accurate in identifying precancerous 
conditions. However with the use of acetic acid (vinegar) the precancerous cells 
temporarily turn white when exposed to the solution therefore making it easy to 
identify them. In other cases iodine-based solution is used which turns normal 
cervical cells brown and the abnormal cells remain yellow or unstained making 
them clearly visible. This has made Visual inspection with added solutions is 
quite reliable in its use as compared to pure visual screening without use of any 
agent. Visual inspection with acetic acid  (VIA)  is suitable for its cost effect 
since it requires low resource settings fow launching and sustaining.Non-
pysician can use this procedure with basic training. (PATH 2000.) 
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In Kerala, India a study was done to evaluate visual screening as a screening 
method. The sudy was carried was recommended for 30 years old and above 
women never the less  younger women that showed up were also tested. 
Routine cytology screening was done in direct comparison to the visual 
scteening method on all of the 2843 participants. Visual inspection was carried 
out with use of a kusko’s self-retaining speculumunder with adequate light from 
electric lamp without the use of magnification. Appearance was recorded in 
categories as unhealthy, prolapse, bleeding on touch, suspicious growth or 
ulcer and hard, indurated, irregular, oedematous cervix. For those found with 
non of the signs were considered normal while those with one or more 
abnormalities were said to be at high risk of  cancer. Cervical smears were also 
taken from each participant using a wooden Ayre’s spatula, the smears were 
fixed with ethyl alcohol and stained by use of papanicolau technique. Findings 
were classified as normal, inflammatory, infection, mild dysplasia, moderate 
dysplasia, severe dysplasia, carcinoma in situ and invasive cancer. Results 
from the visual inspection showed that 1564 (55%) of the women had normal 
looking cervices, 1100 (38.7%) appeared to have low-risk findings and the rest 
179 (6.3%) had high risk categories therefore being considered to have a 
positive visual screening test result. Results from cytology revealed that 178 
(6.2%) had mild dysplasia, 10 (0.4%) had moderate dysplasia, 7 (0.2%) had 
severe dysplasia and 22 (0.8%) had either carcinoma in situ or invasive cancer. 
From this study there were concerns that there might have been some false 
readings in the visual inspection method although the cytology method has also 
been in previous studies been questioned in its validity too although in this 
study that was not of much consideration. In the visual inspection, use of the 
acetic acid impregnation in the cervix improves objectivity and performance of 
unaided visual screening method by helping clear visualization of the cervix also 
known as cervicoscopy. This helps to clearly detect dysplasia that could be 
missed by cervical cytology. (Wesley 1997,436-440.)  
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A study from Italy clearly indicated that cervicoscopy has highsensitivity in 
detecting high grade lensions than pap smear method although it has poor 
specifity. Inspite the shortcoming due to the capability of visual inspection 
method sensitivity it can be merited as a usable screening method. (Wesley 
1997,436-440 ; Cecchini et al 1993.) 
In order to ensure contiuitity  and efficience of the  VIA  as a screening method  
some policies may be used to guideline the implementation of the method. This 
includes broadening of the guidelines in order to ensure that even non-
physician health care providers for example nurses and midwives can easily 
learn how correctly observe and give accurate results.  Adequate and regular 
training needs to be availed for these healthcare workers in this way they can 
maximize their skills in perfoming the VIA test as well as correctly classifying 
their findings. Performace of the VIA methods requires to be constantly 
monitored on its performance and advanced in order to ensure that channels of 
improvement are well utilized to enrichen the  quality of the screening method 
so as to reduce cervical cancer cases. ( PATH 2000, 15-18.) 
HPV DNA Screening; Aimed at detecting high risk HPV types 16, 18, 31, 33, 
35, 39, 45, 51, 52, 56, 59 and 68  which are often  associated with high grade 
cervical intraepithelial neoplasia (HSIL) and invasive cancer in the cervix. 
Technics available in this method of screening include southern bolt hybridation 
which is said to be a laboratory gold standard. It is however labourious and 
tedious and not very suitable for clinical use because it demands for use of 
fresh tissue which is not easy to conduct especially in mass screening 
programmes. A more suitable technic has been use of Hybrid capture 2 assay 
which is mostly used in HPV DNA screening. Samples for the screening are 
obtained from cell suspentions acquired from liquid based cytology or use of the 
cytocervical brush (Kerkal & Kulkarmi  2006, 115 - 122.).  
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In the laboratory the cellular DNA is first denatured and mixed with ribonucleic 
acid probe, the DNA “hybrid” is then captured by antibodies which coat the 
sides of the tube after which a chemical which causes chemoluminescent 
reaction is added, amount of light measured  is what is used to determine 
presence if HPV and its viral load. (Novo et al  2001, 780- 786.) 
 The Bethesda system which was initiated in 1988 and reviewed in 2001 is a 
guideline used alongside the HPV DNA test, it was made to identify 
precancourous lesion in the cervix but is now also used in detecting and treating 
of high grade cervical intraepithelial lesions (HSL). For women with Atypical 
squamous cells of undermined significance (ASCUS) the HPVDNA test  is 
found to be more sensitive in detecting appropriate triage of women about 31% 
to 60% of the women with ASUSC test positive for high risk HPV DNA. Women 
tested positive are reffered to coloscopy, about 98% of the women found to 
have negative results are reliable and reassuring to the patient. (Kerkar  & 
kulkani 2006, 118.) 
In a  study trail was carried out on women from of ages 30 to 60 years in 
southern Finland between the year 2003 to 2005, a total of  58 076 women 
were invited for the routine population based screening programme for cervical 
cancer. The study was done  to determine which method of testing for cervical 
cancer is better, the  conventional cytology screening method or pap smear  
screening was  compared against the HPV DNA test screening method. In both 
arms samples were obtained from a VCE smear which consist of vaginal, 
cervical and endocervical samples taken with cytobrush from the junction and 
endocervix  and with two spatulas from ectocervix and vaginal fornices. In the 
results the HPV DNA screening had more positive readings of any CIN or 
cervical cancer than the conventional cytology screening, clearly identifying the 
HPV DNA test to be more sensitive especially in detecting CIN grade 3 and 
above. The women found to have positive HPV test results were recommended 
for intensive screening. (Anttila et al 2010, 1804.) 
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Despite the good results found with the HPV DNA test compared to the 
conventional test the HPV DNA test does not indicate who needs immediate 
confirmation and treatment. When HPV DNA test is positive cytological 
information is needed to comfirm  who needs a colposcopical examination in 
order to avoid uneccessary coloscopical examination. Treatment of a patient is 
therefore determined by the histological confirmation which is obtained from 
coloscopy directed biopsies and treatments done with the help of colposcope. 
The pap smear is can also used a triage for positive HPV DNA test so as to 
clearly define if the patient needs colposcopy. (Anttila 2006, 1-8.) 
Screening in Finland;  The Finnish cancer registry is responsible for inviting 
women for the cervical cancer screening programme which has been the 
leading method by which the cervical cancer cases have been lowered in 
number by way of early detection and prevention. Municipalities in Finland have 
the responsibility to carry out the invitations in the primary health care centers 
where trained nurses or midwives can take the screening samples. Women at 
the age of 30 to 60 years old are invited for the screening in intervals of five 
years, in some municipalities however the screening invitations age starts form 
25 to 65 years.  Approximately 250,000 women are invited for the screening 
and of this 200,000 women attend. About 600 cervical intraepithelial lesions 
(CIN) are diagnosed through the programme and 200 deaths are prevented 
annually. Mortality rate has decreased by 80% from the baseline. Approximately 
50 to 70 deaths caused by cervical cancer. (Finish Cancer Research 2010).  
Results from the year 1963 indicated a mortality rate of 15 per 100,000 women 
which has decreased to 4 per 100,000 women from results indicated in 2007, 
however incidence of cervical cancer have increased especially  among young 
women, this increase had been due to the large increase in sexual behaviours 
and smoking in the recent decades (Van der Aa et al  2007,8). 
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In 2003 results given by the Finnish mass screening registry reported less that 
60% of the women between the age of 40 years that were invited for the 
screening programme attended and about 20% of those aged 25- 30 years of 
age invittees attended which was an evident indication of how the continuous 
ignorance of the people contributes to the increase in cervical cancer that the 
country work so hard to eliminate. (Harper 2010, 594-595.) 
 
2.3 Vaccines 
There are two types of vaccines that have been produced and approved for 
use. These vaccines are Gardasil which was approved by food and drugs 
administration (FDA) produced by (Merixk,white house station,NJ) the other one 
was Cervarix produced by (Glaxo smithkilne,Philadelphia,PA) and is now 
approved in Australia and europe with continous evaluation  under the  FDA.     
(Godrey J.R. 2007,139-1401.) The vaccines are both administered as 
prophylactic vaccines which means they are specially made for preventing 
against possible HPV infections as opposed to acting as therapeutic vaccines 
which treat acquired infections. For a person to be well protected they have to 
be administered with the three dose series. (National Centre For Immunisation 
Research & Surveillance 2010). Adolescent girls that have been vaccinated 
should also attend screening programmes when they are of age since the 
vaccines cannot protect about 30% of the HPV types therefore the need to 
monitor their status. (Jermal et al. 2011,79.) 
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Gardisal; The drug is made from composition of L1 protein of HPV types 
6,11,16 and 18 which are combined with an aluminum adjuvant. It is a 
prophylactic drug meaning that the main aim is to prevent infection of HPV 
virus. Three dose series are administered recommended for females at the age 
of 11-15 years of age, however it can be administed to girls as young as 9 years 
old. Effect has been found to be 100% effective in preventing cervical 
intraepithelial neoplasia 2 and 3, and  also adenocarcinoma in situ. It is 98% 
effect on types 6 and 11  and finally 100% effective on types 16 and 18 
therefore preventing vulval intraepithelial neoplasia. The vaccine is best 
effective if the patient was not infected with any of these HPV types prior to the 
vaccine administration. (Pallecaros 2007, 541.) Gardisil dose which is 
administered in three doses,it is given in 1.5ml dosage intramuscularly. It  can 
begin from the age of 0,2 and 6 months. The second dose can be administered 
after one month of the first dose. The final dose is given atleast 3months after 
the the second dose. (NCIRS 2010.) 
Cervarix; Combinations used to manufacture cervarix drug are virus-like 
particles of  major capsid L1 protein of HPV types 16 and 18 mixed  with AS04 
adjuvant system which contain 3-0-desacyl-4, monophosphoryl lipid and 
aluminum hydroxide salt. The drug was first introduced by Medimmune in 1998 
and after a number of trials it was approved by the FDA in march 2007. It is 
intended for young women between the ages of 10-15 years of age in order to 
prevent cervical cancer, CIN 2 and CNI 1 which are caused by HPV types 16 
and 18..Cervarix was approved in the European union for use  in females by 
determination of efficiency to those aged 15 to 25 years and those by 
determination of immunogenicity ages 10-25. Up to date the vaccine is licensed 
in more than 95 countries all over the world among these it is used in  27 
European countries including Finland. (VRSPAC 2009, 14-16.) 
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So far studies on cervarix vaccine have been done up to three phases and an 
ongoing fourth phase is in place in Finland where a target of 70,000 
adolescents aged between 12-15 years of age. About 30,000 of the adolescents 
will receive the vaccine which will help to evaluate the safety and effectiveness 
of the vaccine against HPV virus. Another  trial is in place in the US where a 
total of 50,000 women vaccinated with cervarix vaccine will be observed for any 
autoimmune disorders or occurrence if any abnormalities in pregnancy for those 
vaccinated. (VRBPAC 2007, 19.) 
Vaccine clinical trial; In another article by Godfrey (2007, 139-1401). Harper  
discussed a research that was done on the  vaccines that are currently  
produced and the effectiveness in prevention of the cervical cancer. Two groups 
of women at the age of 15 - 26 years were administer with three doses of the 
approved the vaccines, the Future 1 group who had not been infected with 
cervical cancer were prior to the vaccination found to have been well prevented 
from cervical lesions (CIN-1,CIN-2 and CIN-3 and also adenocercinoma in situ 
which are caused by HPV 6,11,16 and 18. The vaccine was found to last for 
atleast 3 years. Future 2 who were a similar group as the first in age group and 
had no infection of HPV 16 and 18 previously were found to be completely 
immune from CIN-2,CIN-3 and adenocarcinoma in situ caused by the types 16 
and 18. The vaccine lasted 3 years. The future 1 the  vaccine was found 
effective by 98% accuracy for women that had never been infected with any of 
the mentioned types of HPV while its effectiveness decreased to 55% in women 
that have had infection prior to the vaccination. In the Future 2  the vaccine was 
found to be 95% effective in women never infected with the  types HPV virus 16 
and 18 while the affectivity reduced to 44% in those infected with the virus at 
the time of vaccination. From these trial a recommendation for women sexually 
active was made as well as middle school girls even if they are not yet sexually 
active, although this brought contravacy that the girls maybe too young to this 
kind of exposure but it is necessary to reduce the rate of cervical cancer by 
creating awareness. Even though the vaccine is not yet 100% assured 
protection , studies are still been done to improve the vaccines, regular 
screenings go a long way in knowing ones status. (Godrey  2007,139.) 
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Both doses are usually administered in three doses each containing 0.5 ml 
intramuscular injections in a period of six months. Patients injected with the 
vaccines experienced some adverse events on the injection sites such as 
pain,erythema and oedema but no serious problems were experienced. Women 
that havd not had past HPV genotype infections prior to the vaccine were found 
to have 90% protection. The vaccines cannot protect against existing HPV 
infection therefore it is best administered before a woman is sexualy activite 
which in some cases is girls from the age of 11 to 13 years. (WHO 2007, 7-11.) 
 
2.4  Treatments for cervical cancer 
Cervical cancer is curable if detected and treated at an early stage,about 80% 
of those detected at the early stage are cured with suitable treatments.In 
developing countries cervical cancer’s are often diagnosed at very late stages 
due to the poor or even lack of good screening ang treatment methods as 
opposed to the developed countries that have continuously been able to detect 
and treat early stages of cervical cancer mostly in the precancerous stages. 
(ACCP 2004.) 
Some treatments that are used in developing countries include cryotherapy 
which involves the use of extremely low temperatures that destroy the abnormal 
tissues. This method does not require electricity therefore making it a cheap 
affordable method that can be used by low-income states. Loop electrosurgical 
excision procedure (LEEP) is another method that involves use of thin wire in 
removal of affected parts, although slightly more expensve than cryotherapy, 
LEEP has better performance since it allows extractions of tissues for biopsy to 
allow further investigations and reducing possibility of advanced cancer. 
(Ashford 2005, 3.) 
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In different countries studies have been done on the success of sceening and 
treatment of cervical cancer, more diagnosis of early stages are being detected 
due to the females willingness to voluntarily participate in the screening 
process. The table 2 below describes some of the countries participation in 
studies and the outcomes in relation to early stage detection. The outcome was 
also affected by the population factor as well as developmental states of the 
countries. (ACCP 2004.) 
SEE TABLE  2 
Table 2. Cases of cervical cancer in develop and developing counties.    
Source;  ACCP 2004, 212 .  http://www.rho.org/files/ACCP_mfm.pdf. Updated 
2.5.2011 
country period of study  womenwith 
cervical cancer 
Women with  ealy 
stage(localized 
cancer 
Cuba  1988-89 831 24,1% 
Mumbai,India 1982-86 8,861 11.7% 
Chennai,india 1984-89 6,141 6.8% 
Rizzal,philippines 1987 937 5.2% 
Chaing Mai,Thailand 1983-92 3,231 20,7% 
Kampala,Uganda 1995-97 261 14.6% 
Seer,USA 1992-98 7,594 54,0% 
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Previously early stage cervical cancer wes treated radically through 
radiotherapy or radical hysterectomy, every five years the survival rates were 
placed at about 80-90%. Radiotherapy is the external beam and intracavity 
treatment. In 1999 a National Cancer Institution recommended that radiotherapy 
should be used alongside chemoradiation for women with advanced stages of 
cervical cancer, this was based on five randomized trials that showed evidence 
of better survival with progressive cancer free survival. (Tierney 2009, 8.)  
 Surgery may be recommended for small tumors in the cervix especially when 
the patient has no sign of metastasis in the lymph node. Some of the surgical 
procedure are like hysterectomy that was mentioned earlier. This is a surgical 
procedure that involves removal of the uterus, there are two types of 
hysterectomy namely simple hysterectomy that involves removal of the uterus 
and the cervix. the surgery is done laparoscopically  and takes a very short time 
of recovery with one to two days of hospitalization. Radical hysterectomy 
involves removal of the uterus and about two centimeters of the upper vagina 
and soft tissues around the cervix,  the procedure may be done laparpscopically 
therefore taking less recovery time but may cause some effect on the bowel and 
bladder function. After radical hysterectomy a pateient is hospitalized for at least 
6 weeks with a urine catheter and an abdominal drainage which are removed 
three to five days after operation, the patient should not have sexual intercourse 
until atleast six weeks. Pain relief medication can be administed for pain 
management. (National center for gynecological cancer 2010, 3-6.) 
Like hysterectomy radical trachelectomy is surgeury that captures the early 
stages IA1,IA2 and IB1, as opposed to hysterectomy,trachelectomy is done with 
the aim to preserve fertility therefore suitable for young women. In advaneced 
stage treaments one of the  treatments methods used is intracavitary 
brachytherapy where radioactive sources are placed close to the targeted 
tumor. This dose can  decline rapidly  beyond the tumor therefore stopping 
further growth of the tumor towards the bladder and rectum. (Long et al 
2007,1570.) 
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3  PURPOSE AND AIMS 
Purpose of this Bachelor thesis to create cervical cancer awareness on tests 
and vaccines available in Finland. The aim is to produce a webpage on 
terveysnetti which is for patient education where patients can easily access 
understandable information that they can refer to for further knowledge on 
cervical cancer. 
 
4 IMPLICATION OF THE PROJECT 
This bachelor’s  thesis  has been collectively written to target the community 
especially the female gender of all ages. The goal is to create awareness on 
cervical cancer to the women that have not heard of it and those with miss 
information on its nature. 
Through the terveynetti which is an internet page set for the public use in salo 
community to educate them on various health concern issues, the readers will 
be able to access information on cervical cancer  mainly forcusing on different 
methods of screening and vaccines prevent to fight the HPV infection. 
This works as an empowering tool for the women to self educate themselves at 
the comfort of their settings.  
Women may not be able to voluntarily visit health centers seeking information 
on cervical cancer. Information that will be provided in the terveysnetti webpage 
will be set out to empower the women with this information  easing  the  
discomfort by giving the basic information eliminating the fear to visit the topic of 
cervical cancer with their physicians and although physicians empathize with 
the patient’s concerned they struggle to find ways to reach out to the reach out 
the women. (Hill et al. 2011, 2645.) 
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5   HEALTH EDUCATION 
Patient education is a process that influences a patient´s behavior providing 
knowledge , attitudes and skills that the are necessary for the patient to improve 
their health. Providing education empowers the patients with complete and 
current information which helps create a sense of trust towards health workers 
which help them create a self will for better life  health related choices. 
(American academy of family physicians 2008, 1-2.)  
Cervical cancer has been the leading deadly cancer in developing mainly as a 
result of lack of organizations for screening programmes. Research has 
continuously proven that women with knowledge on cervical cancer respond 
positively to the great need for  screening. In hondures a developing country 
incidents of cervical cancer are 39,6/100 000 which is four times the number in 
the united states which shows how greatly education on cervical cancer goes a 
long way. (Perkins 2007, 187-193.)  
According to many studies that have been carried out  it was found that the 
more knowledge women had on cervical cancer and importance of screening 
the more likely they were to visit the screening center as opposed to 
socialeconomically challenged women that had insuffieicent knowledge on 
abnormal pap test results and the need for continous follow-ups such as 
coloscopy. Women tend to identify pap test as a test for sexual disease that one 
should inform her partner on her abnormal result as is the case with STDS such 
as HIV/AIDS, this clearly indicates the poor knowledge of the relation between 
sexual behaviours and the HPV  virus. (Radecki 2005, 78-84.) 
With cervical caner records still globally high, in 2005 was recorded a total of 
260,00 cervical cancer deaths with 95%of these from developing countries. This 
great bridge of difference between developed and developing countries has ben 
among other reasons due to lack of cervical cancer awareness in communities 
and also in their healthcare system. (Nnodu et al. 2010, 96-98.) 
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Women that get  positive HPV test results  respond with anxiety and usually 
have a sense of guilt and shame due to the fear of the stigma that comes with 
sexually transmitted infections. (RCN 2006, 3, McCaffery 2003 ). This kinds of 
fears of judgement come from the women lacking clear information on the 
difference between HPV high risk infection and wart virus and the also  HPV 
infection’s relation with cervical cancer. Healthcare educaters are responsible to 
provide this education and are trusted to give accurate information,this helps 
women evaluate their status well reducing anxiety. (RCN 2006, 4.) 
6 ESTABLISHING WEBPAGES 
The web is in the recent days used for information and also for disseminating of 
information both public and private organizations worldwide. (Gullikson 1999, 
293). Educators and student especially rely on the educational webpages for 
information therefore it is important to have creadible resources that can be 
trusted with suitable truthful in data. Educators forcus on audience, credibility, 
accuracy, objectivity, coverage and currency in choosing a well suitable 
webpage. (Boklaschuk  2001, 2-3.) 
Impact of the webpages on its users is therefoe important and visual 
appearance of the web page design is always a prior determinant of whether 
the user are interested in using the page. Although a major determining factor 
other factors falls in place such as the utility of the page which is the ability of 
the web site serving intended purpose to the users by giving suitable and 
correct information. The third important factor is usability of the page for the 
users,it should be easy and navigate. (Gullikson 1999, 293-296.) 
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Webpages are to be established obtain retrieved information from this bachelor 
of thesis research work. The webpages  are intended for the terveysnetti which 
is a page targeting the public net users developed by the Turku university of 
applied sciences  in collaboration with the salo city hospital in order to inform 
and educate the society. Group targeted mostly for this study webpages are 
mainly women both older married women as well as young women that are at 
their sexual active stages. The webpage may also be useful in giving 
information to men that may probably have women close in their lives that may 
be going cervical cancer and may wish to be more informed on it but feel to 
intimidated to voluntarily ask medical health workers information. (Hill et al. 
2011, 2645.) 
The information in the webpages like in the bachelor thesis has information of 
the screening methods that are available for cervical cancer as well as the up to 
date vaccines that are currently approved and available against cervical cancer. 
Just like in the bachelor’s thesis some information has also been metioned 
about available treatments. 
The language used in the webpages is Engish, this language was selected 
since it is the main language that has been used in writing the bachelor’s thesis 
paper, therefore tranferation of information from the paper to the webpages is 
easy and direct. Simple vocabulary has been used in the webpages to ensure 
that users are easily able to understand the information. This information may 
also in the future be translated into various languages including finnish in order 
for a wider range of readers to be able to read the data if they do not 
understand English. 
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7 DISCUSSION 
7.1 Reliability and validity    
Consistance in information borrowed is essential while taking on literature 
review. The information given in this paper is a direct reflection on the articles 
that have been reviewd and used (Golafshani 2003,598.) Majority of these 
articles are peer reviewd articles meaning that they have been studies and 
approved by academic critics therefore making can be considered suitable for 
use. Keywords were used constantly in the search in order to ensure that 
relevant information found was in direct relation with the topic as well as the 
subtopics, it also aided in simplification and narrowing down of articles ensuring 
that the best articles were selected. 
The research  done  measures truly in accordance to it intended purpose and 
also on the truthfulness of the research. (Golafshani 2003, 599.) Information 
provided in this bachelor’s thesis is in accordance to the set purpose and aims 
and sufficient concentration has been placed on the test and vaccines for 
cervical cancer ensuring that there is no diversion of interest. 
7.2 Ethical consideration 
Personal views and opinions were not used in the bachelor’s thesis literature 
review avoiding any  bias opinions in the content provided. Information 
borrowed from various articles clearly reflects information as the authors 
intended to portray without plagiarism. This means that even thought the 
information is similar to that of the  found in the literature sources used but non 
of this information nor diagrams have been copy pasted directly from these 
articles. (Howe & Moses 1999, 21.) 
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Data used was from articles that were written under diverse cultures and 
academic institutions as well as independent organizations. This has therefore 
helped in maintaining diverse community study of cervical cancer and 
preventing segregation of stigmatization of a different kinds of  communities and  
groups of women. With the knowledge that cultural barriers are present in may 
communities it is important to know how to break down the walls of ignorance 
without causing conflict in the societies or problems to the women. (Coughlin 
1998, 112.)    
7.3 Limitations    
Limitations were sighted in the study and collection of data fro this bachelor’s 
thesis paper. Some of the limitations involved method of research that was in 
use. Articles collected for use were  randomly selected by use of keywords in 
many different webpages and also use of advanced google. By use of this 
method it is more than likely that although articles selected and used were 
suitable, so many more articles that may have been suitable were not found or 
ignored in the search. Some articles that were also found were in abstract form 
and could not be found in full test therefore being set aside and not included in 
the paper. Language was also a barrier in the use of some of the articles found 
since they were in different languages other than English language therefore  
were dismissed and not used in the study. 
This bachelor of   thesis paper was mainly forcused on screening techniques for 
cervical cancer and vaccines available as was the aim project therefore little 
information was mentioned on treatments available. This may fall as a limitation 
for a reader that may be seaking information on the treatments. 
The topic was fairly wide and therefore demanding summary of information 
collected. In this process important information may have been left out causing 
a shortback in the work. Too much sieving of information may also have led to 
omition of relevant and maybe necessary information. 
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7.4 Conclusion and reccomendation  
HPV virus is the leading risk for cervical cancer and the choice to go or not to 
go for cervical cancer screening is a leading factor to the survival rate of the 
human race and especially the female gender. A variety of cervical cancer 
screening techniques have continued and are continued to be introduced and 
mordified in order to be able to successfully trace risky HPV types such as 
types 16 and 18. Pap smear screening is the most common method of 
screening but it has been seen to have some loopholes therefore the need for 
the creating new methods of screening which have been mentioned in this 
study. (Kerker 2006,115-122.) 
To enable the fight against cervical cancer countries need constant running 
programmes that aid in the initiation and funding. Most developing countries  
have these kind of programmes already running and are managed by the major 
health institutions and funded by the states. However in some countries 
especially developing countries where there is poor infrastructure external 
donors step in to fill in the void. (Collymore & Ashford 2005, 2-5.) 
Alliance of cervical cancer prevention which was started in 1999 to asses and 
promote prevention of further spread of cervical cancer is one of these 
nongovernmental international organisations. The ACCP projects have worked  
over the years towards introducing  good quality affordable screening methods 
for the women in he developing countries. The aim of the projects is usually to 
use local understandable messages for the local women in order for them to 
understand the great need to participate in the screening, the targetted group of 
women for the ACCP screening project are those in their 30s and  40s who are 
screened for abnormal cells. Health centers are opened up for outpatient visits 
as well as information centers for women that want to know more on HPV virus. 
(ACCP 2005.)  
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Other organizations that have continued to work independently  and alongside  
ACCP are the Program for Appropriate Technology in Health (PATH) and the 
World health organization (WHO). A group of many organisations came 
together in 2007 to create the global coaltion to stop cervical cancer  named the 
cervical cancer action (CCA) the organization aim is to “expedite the global 
availability,affordability and accessibility of new and improved cervical cancer 
prevention technologies to women in developing countries.” (Cervical Cancer 
Action  2007. ) 
Female morbidity and mortality have significantly  decreased in the period of 
time showing evidence of success in the programmes that have been created 
under the alliance for cervical cancer as well as working independently. 
(Cervical Cancer Action 2007). However there is still a long way to go as so 
many populations have not yet been reached and still the fear of women 
especially those tied by culture and religion fell they do not want to go into the 
health clinics to consult on the disease or have screening even when the 
facilities are made available to them. ( ACCP 2004, 3.) 
Women need to step up to the challenge and participate in the screening 
programmes closest to them for monitoring and also play a role in creating 
awareness to those around them. With this cases of cervical cancer will 
significantly increase the interest among th population and decrease incidents.  
In developed countries the change of lifestyle remains one of the big concerns, 
although the tests and vaccines are available many have chosen to ignore the 
risk that HPV infection holds and  instead on  engaging  in the same habits that 
post the risk. This can be changed by beginning to change these attitude by 
educating the women on the importance of preventing the HPV virus . (Bingham 
et al. 2003, 410.) 
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Cervical cancer is considered to be a sexually transmitted condition but it is 
important for one to understand that other sexually transmitted agents are the 
ones that contribute to the growth of the HPV virus such as sexually transmitted 
diseases for instance chlamydia, HIV virus, herpes simplex virus type 2 and 
other organisms that cause bacterial vaginosis. Although these infections can 
be prevented by use of condoms  the HPV virus cannot be prevented in by use 
of condoms but by the ensuring that one is sexually  responsible by maintaining 
the same sexual partner and also attending the cervical cancer screening 
programmes as adviced by the physician. (Stone et al. 1995, 409.) 
 
 
 
 
 
 
 
 
 
39 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
 
SOURCE MATERIAL 
Alliance for cervical cancer prevention. 2004. ACCP strategies for supporting women wih 
cervical cancer.  Cervical cancer prevention issues in Depth No 2,  7  Consulted 5.08.2010 
Alliance for cervical cancer prevention 2009. New evidence on the impact of cervical cancer 
screening and treatment using HPV DNA tests,visual inspection, or cytology; Cervical cancer 
prevention fact sheet.  2009,1-3. Consulted 2.5.2011     
http://www.rho.org/files/ACCP_mfm.pdf 
American academy of Family physicians. 2008. Patient Education: Recommended curriculum 
guidelines for family medicine residents. 284/2008, 1-2.  Consulted 30.09.2011 
American collage of obsterticians and gynocologists. 2009. Clinical management guidelines for 
obstetricians-Gynocologists. 109/ 2009. Consulted 8.5.2011 
American Cancer Society. 2010,1-9.  Cervical cancer. Consulted 2.05.2011 
http://www.cancer.org/acs/groups/cid/documents/webcontent/003094-pdf.pdf 
Anttila, A.; Katoniemi-Talonen, L.; Lainonen, M.; Hakama, M.; Laurila, P.; Tarkkanen, J.; Maila, 
N. &  Nieminen, P. 2010. Rate of cervical cancer, severe intraepithelial neoplasia and 
adenocarcinoma in situ in primary HPV DNA screening with cytology triage; randomized study 
within organized programme. BMJ journal 340/2010, 1804. Consulted 27.04.2011 
Anttila A. 2008. Alternative screening methods within the organized screening programme for 
cervical cancer Finland. Mass screening registry, Finnish cancer registry. Consulted 10.05.2011 
Anttila, A.; Hakama, M.; Kotaniemi-Talonen, L. & Nieminen, P. 2006. Alternative technology in 
cervical cancer screening:a randomized evaluation trail. Biomed central public health journal  
Vol. 6 No. 252/2006, 1-8. Consulted 10.05.2011 
 Ashford, L. & Collymore, Y. 2005. Preventing cervica cancer worldwide. Population Reference 
bureau. Policy brief. Consulted 6.8.2011 http://www.prb.org/pdf05/PreventCervCancer-
Brief_Eng.pdf 
Bingham, A.; Bishop, A.; Coffey, P.; Winkler, J.; Bradley, J.; Dzuba, I. & Agurto, I. 2003. Factors 
affecting utilization of cervical cancer prevention servicesin low – resource settings. Salud 
publica de mexica Vol. 45 No. 3,410. 
40 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
Boklaschuk, K. & Casse, K. 2001. Evaluation of Educational websites. EDCMM 802.6/2001. 
Consulted 20.10.2011 
http://www.usask.ca/education/coursework/802papers/bokcaisse/bokcaisse.pdf  
 Cancer Research UK (CRU) 2008.Treating cervical cancer – A quick guide. Consulted 
9.6.2011 
http://www.cancerhelp.org.uk/prod_consump/groups/cr_common/@cah/@gen/documents/gener
alcontent/treating-cervical-cancer.pdf  
Castellsague, X.; Bosch, X. & Munoz, N. 2003.  The male role in cervical cancer. Salud publica 
de mexico. Vol. 45 No. 3,346. 
 
Cervical cancer Action. 2007  New options for cervical cancer screening and Treatment in Low-
resource settings. Consulted 9.6.2011 
http://www.cervicalcanceraction.org/pubs/CCA_cervical_cancer_screening_treatment.pdf  
Cecchini, S.; Bonardi, R.; Mazzotta, A.; Grazzini, G.; Lossa A & Ciatto, S. 1993.  Testing 
cervicography and cervicoscopy as screening tests for cervical cancer. Tulnori 79, 22-25. 
Consulted 3.10.2011 
Collymore, Y.; Ashford, L. 2005. Preventing cervical cancer worldwide. Population reference 
bureau. Policy brief. Consulted 9.6.2011 
http://www.prb.org/pdf05/preventcervcancer-brief_eng.pdf 
Coughlin, S. S. 1998. Cancer prevention and control research among Houma Indian women. 
Ethics in epidemiology and public health practices: colleted works. Library of congress catalog. 
No. 97-75537, 111.  Consulted 6.10.2011. 
Data, S. D.; Koutsky, L. A.; Ratelle, S.; Unger E. R.; Shlay J.; McClain, T.; Weaver, B.; Kerndit, 
P.; Zenilman, J.; Hagnesee, M.; Suhr C.J.; Weinstock H. 2008. Human papillomavirus infection 
and cervical cytology in women screening for cervical cancer in the United States, 2003-2005. 
Journal of Ann med. Vol. 148, 493-500. Consulted 12.01.2011 
 Fry, M.; Ferries-Rowe, A.; Learman, L. & Haas, D. 2010. Pap smear versus speculum 
examination; can we teach providers to educate patients? Department of obstetrics and 
Gynecology, Indiana University school of Medicine, Indianapolis, Indiana. Journal of women´s 
Health Vol. 19 No. 9,1715-1719. Consulted 14.01.2011 
 Godfrey, J. 2007. Towards optimalHealth, Diane M.Harper, M.D., M.S., M.P.H. Discusses the HPV 
vaccine and prevention of cervical cancer. Journal of women´s Health Vol 16 No 10,139-1401. 
Consulted 14.01.2011 
41 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
Golafshani, N. 2003. Understanding Relaibility and Validity in qualitative research. The quality 
report Vol. 8 No. 4,597-609. Consulted 30.9.2011. 
Gullikson, S.; Blades, R.; Bragdon, M.; McKibbon, S.; Sparling, M. & Toms, G. 1999.  The impact of 
information architecture on academic site usability.The electronic library  Vol. 17 No. 5, 292-296. 
Harper, D.M.; Nieminen, P.;Paavonen, J.; Lehtinen, M. 2010. Cervical cancer incidence can 
increase despite HPV vaccination. The lancet infectious diseases Vol. 10 No. 9, 594-595. 
Consulted 7.04.2011 
Herbert, J. & Janis, C. 2008. Reducing patient risk for human papillomavirus infection and cervical 
cancer. Journal of the American osteopathic association Vol. 108 No. 2, 65-70. Consulted 
9.5.2011. 
Hing, E.; Saraiya, M. & Roland, K..B. 2011. Liquid-based Cytology Test use by office-based 
physicians.United States, 2006-2007. National Health Statistics. 40/2011, 2-8. Consulted 9.5.2011 
Hill, E. K.; Sandbo, S.; Abramsohn, E.; Makelarski, J.; Wroblewksi, K.; Wenrich, E.; Mccoy, S.;  
Temkin, S.; Yamada, D & Lindau, S. T. 2011. Assessing gynecologic and breast cancer survivor’s 
sexual health care needs. American cancer society Vol. 117 No. 12, 2643-2651. Consulted 
9.5.2011 
Howe, K. & Michele, M. S. Ethics in education research. Review of research in education Vol. 24, 
21. Consulted 6.10.2011 
Imaginis. 2008. cervical cancer –Risk factors and symptom.The women’s Health resources.July 
2008. Consulted 9.05.2011 http://www.imaginis.com/cervical-cancer/cervical-cancer-risk-factors-
and-symptoms-2 
Jemal, A.; Bray, F.; Center, M; Ferlay, J.Ward, E. & Forman D. 2011. Global cancer statistics.CA; A 
cancer journal for clinicians Vol. 61  No. 2, 61-90. Consulted 9.5.2011. 
kerkar, R. and  Kulkarni, Y. 2006. Screening for cervical cancer:an overview.Journal of obstetric 
and  Gynecology of India. Vol. 56 No. 2, 115-122. Consulted 9.5.2011 
Lehtinen, M,; Ault, K.; Lyytikainen, E.; Dillner, J.; Garland, S.; Ferris, D.; Koutsky, L.; Sings H.; Lu 
S.; Haupt, R. & Paavonen J. 2011. Chlamydia trachomatis infection and risk of cervical 
intraepithelial neoplasia. Sexually transmitted infectios. BMJ Journal Vol. 87, 372-376. 
Likes, W. & Itano, J. 2003. Human papillomaviruses and cervical cancer; not just a sexually 
transmitted diseases. Clinical journal of oncology Nursing, USA Vol. 7 No. 3, 271-306  
Long, J.H.; Laack, N. L. & Gostout, B.S. 2007. Prevention,diagnosis and treatment of cervical 
cancer; mayo clinic proceeding Vol. 82 No. 12/2007, 1567-1570. 
42 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
McCaffrey, K.; Forrest, S.; Waller, J.; Desai, M.; Szarwski, A. & Wardle, J.2003. Attitudes 
towards HPV testing: a qualititative study of beliefs among Indian, Pakistani, African – Caribean 
and white British women in the UK. British journal of cancer. Vol. 88 No. 1, 42-46. 
National centre for Immunisation Research & Surveillance. 2010. Human papillomavirus (HPV) 
vaccines for Australians: Information for immunization providers. Consulted 9.6.2011 
http://www.ncirs.edu.au/immunisation/fact-sheets/hpv-papilloma-virus-fact-sheet.pdf 
National center for gynecological cancers. 2010. Treatment for cervical cancer; cancer 
Australia, pg 3-6. 
Nnodu, O.; Erinosho, L.; Jamda, M.; Olaniyi, O.; Adelaiye, R.; Lawson, L.; Odedina, F.; 
Odumuh, T.; Isu, N.; Imann, H.; Owolabi, O.; Yaqub, N. & Zamani, A. 2010. Kwowledge and 
attitudes towards cervical cancer and Human papillomavirus: A Nigerian pilot study. African 
journal of reproductive health. Vol.14 No. 1,96-98. Consulted 6.09.2011 
Nouvo, J.; Melnikow, J. & Howell, L. 2001. New tests for cervical cancer screening. Journal of 
the American academy of family physicians Vol. 64 No. 5,780-786. Consulted 14.01.2011 
Özgul, N. 2009.  The state of cervical cancer in turkey and cervical cancer screening studies; 
Ankara, Etlik Maternity and gynecology training and research Hospital, Ministry of Health, 
Turkey, pg 349. Consulted 12.08.2011. 
 Pallecaros, A. & Vonau, B. 2007. Human papilloma virus vaccine-more than a vaccine.current 
opinion in obstetrics and gynecology 2007 Vol 19, 154-546  Consulted 06.05.2011 
Perkins, R.B.; Langrish, S.; Stem, L.; Simon, C. 2007. A community-based education 
programme about cervical cancer improves knowledge and screening behavior in Honduran 
woman.Rev panam Salud Publica  Vol. 22 No. 3/2007,187-193 
Pink book; Course textbook ; The human papilloma virus. Chapter 10/2011. Cosulted 3.11.2010 
http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hpv.pdf  
Powe, B. 2006. Perception of cancer fatalism and cancer knowledge: A comparison of younger 
and older African American women. Journal of psychological oncology.Vol. 24. (Abstract). 
Consulted 3.11.2010. 
Program for Appropriate Technology in Health (PATH). 2000. Planning appropriate cervical 
cancer prevention. Consulted 5.6.2011 
Radecki, C.; Pearson, H.C.; Breltkopf, D. M. 2005. Poor knowledge regarding the pap test 
among low-income  women undergoing routine screening. Perspectives on sexual and 
reproductive Health Vol. 35 No. 2, 78-84 
43 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
Roland, K.; Bernard, V.; Saraiya M.; Hawkins, N.; Brandit, H.& Friedman, A. 2009. Assessing 
cervical cancer screening guideline in patient education materials. Journal of women´s Health. 
Vol. 18 No. 1, 5-12 Consulted 20.01.2011 
Rosario, A.M. 2010. Meeting Chamorro women’s health care needs: Examining the culture 
impact of Mamhlao on Gynaecological screening.Pacific Health Dialog.Vol. 16 No. 1/2010, 81-
82.   
Royal collage of Nursing. 2006. Human papillomavirus (HPV) and cervical cancer- the facts. 
Consulted 6.7.2011  
http://www.rcn.org.uk/__data/assets/pdf_file/0011/78716/003083.pdf                   
Saonere, A.J. 2010. Awareness screening programmen reduces the risk of cervical cancer in 
women.African journal of pharmacy and pharmacology Vol. 4 No. 6, 314-323. Consulted 
5.7.2011 
Scottish Intercollegiate Guideline Network (SIGN) 2008. Management of cervical cancer. A 
national clinical guideline. Consulted 06.05.2011 http://www.sign.ac.uk/pdf/sign99.pdf 
Snadden D. 1992. Ethical dilemmas of cervical cancer screening. Canadian family physician Vol 
38, 331-333. Consulted 12.10.2011. 
Stone, K. M.; Zaidi, A.; Rosero- Bixby, L.; Oberle M. W.; Reynolds, G.; Larsen, S.; Nahmias, A. 
J.; Lee F. K.; Julius, S. and Guinan, M. E. 1995. Sexual behavior, sexually transmitted diseases 
and risk of cervical cancer. Journal of epidemiology Vol. 6 No. 4, 409 
Tierney J. 2009. Neoadjuvant chemotherapy for lcally advanced cervix cancer (review). 
Neoadjuvant chemotherapy for cervical cancer Meta- analysis collaboration. 4/2009, 2- 9. 
Vaccine and Related Biological products Advisory committee(VRBPAC) 2009. Cervarix. 
VRBPAC briefing Document. Food and Drugs Association  Consulted 06.05.2011  
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccine
sandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM181371.pd
f 
Van der Aa, M.; Pukkala, E.; Coebergh, J.; Antilla, A. and Siesling, S.2007. Mass screening 
programmes and trends in cervical cacner in Finland and the Netherlands. International journal 
of cancer Vol. 122, 8. Consulted 06.05.2011 
http://onlinelibrary.wiley.com/doi/10.1002/ijc.23276/pdf  
44 
 
TURKU UNIVERSITY OF APPLIED SCIENCES THESIS | Grace Kamau 
 
Wesley, R.; Sankaranarayanan, R; Mathew B; Chandralekha, B; Beegum, A; Amma, N and 
Nair, M. 1997. Evaluation of visual inspection as a screening test for cervical cancer. British 
journel of cancer Vol. 75 No. 3, 436-440. 
 
WHO. 2002. Cervical cancer screening in developing countries. Report of the world health 
organization consultation  Consulted 14.09.2010 
 http://whqlibdoc.who.int/publications/002/9241545720.pdf  
WHO 2007. Can we prevent cervical cancer? The European magazine for sexual and 
reproductive health No 64/2007. Consulted 10.05.2011  
http://screening.iarc.fr/doc/en64.pdf  
 
 
 
 
 
 
 
 
